Connect
← Return to John Hopkins Webinar on transplant recipients and vaccines
Discussion
John Hopkins Webinar on transplant recipients and vaccines
Transplants | Last Active: Jan 13, 2022 | Replies (141)Comment receiving replies
Yes, you’re correct, it’s 17%. We’ll just have to keep following the results and be hopeful. I’m on both Tacrolimus and MFF, so both seem to present issues with developing resistance to the virus.
Replies to "Yes, you’re correct, it’s 17%. We’ll just have to keep following the results and be hopeful...."
Connect
Did anyone catch the link to view the webinar post presentation? I would like to share this with my family. Thanks.